Personalizing colorectal treatment strategies through machine learning |
Jean-Emmanuel Bibault |
Stanford University |
PLCO |
Feb 27, 2020 |
PLCO-592 |
Treatment effect on the Survival Time of Lung Cancer Patients |
Jing Zhou |
Department of Family and Preventive Medicine |
PLCO |
Feb 27, 2020 |
PLCO-591 |
A Machine Learning Approach to Diagnosing Breast Cancer |
Michele La Ferla |
University of Malta |
PLCO |
Feb 19, 2020 |
PLCOI-585 |
Developing a metabolite-based biomarker panel for prostate cancer detection and prognosis in African-American men |
Arun Sreekumar |
Baylor College of medicine |
PLCO |
Feb 19, 2020 |
PLCO-583 |
Second-hand smoke (SHS) and mortality in never-smoking women |
Neal Freedman |
NCI |
PLCO |
Feb 19, 2020 |
PLCO-586 |
A new mathematical model for the computation of optimal screening frequencies for lung and colorectal cancer |
Johannes Reiter |
Stanford University |
PLCO |
Feb 7, 2020 |
PLCO-581 |
Bayesian network in differential diagnosis of head and neck cancer |
Kamila Bukirova |
Near East University |
PLCO |
Feb 7, 2020 |
PLCO-571 |
Evaluation of dietary methionine intake and breast cancer incidence |
Vincent Cryns |
University of Wisconsin Madison |
PLCO |
Feb 7, 2020 |
PLCO-579 |
Personalizing Lung Cancer Screening for Smokers with Comorbidities |
Minal Kale |
Icahn School of Medicine at Mount Sinai |
PLCO |
Feb 7, 2020 |
PLCO-578 |
A new method to estimate the predictive value in a screening program |
Jian-Lun Xu |
NCI |
PLCO |
Feb 7, 2020 |
PLCO-580 |
Secondary analysis of association between ethnicity and endometriosis when adjusted for age at first pregnancy using data from the PCLO-dataset |
Frank Teunissen |
London School of Hygiene and Tropical Medicine |
PLCO |
Feb 3, 2020 |
PLCO-569 |
Clicque CLARA Rebuild |
Zui Yong Poong |
CLICQUE TECHNOLOGY SDN. BHD. |
PLCO |
Feb 3, 2020 |
PLCOI-575 |
Evaluating existing data on circulating inflammatory markers in relation to history of benign gynecologic pathology and history of oral contraceptive use. |
Lauren King |
NCI-DCEG |
PLCO |
Jan 30, 2020 |
PLCO-576 |
Use of Tobacco Biomarkers in Lung Cancer Risk Assessment |
Christine Lambert |
University of Minnesota |
PLCO |
Jan 30, 2020 |
PLCO-563 |
Prostate cancer risk prediction using clinical risk factors and genetics |
Nathan White |
Multimodal Imaging Services Corporation, dba HealthLytix |
PLCO |
Jan 30, 2020 |
PLCO-574 |
Identification of High-Risk Cohorts using PLCO data for Targeted Gastric Cancer Prevention and Control Strategies |
Haejin In |
Albert Einstein College of Medicine |
PLCO |
Jan 27, 2020 |
PLCO-567 |
Uncovering roles of polyunsaturated fatty acids (PUFA) in pancreatic cancer etiology: a gene-diet interaction study |
Lang Wu |
University of Hawaii at Manoa |
PLCO |
Jan 27, 2020 |
PLCO-573 |
Dietary fiber, whole grains and risk of hepatocellular carcinoma |
Katherine McGlynn |
National Cancer Institute |
PLCO |
Jan 27, 2020 |
PLCO-554 |
Development of a machine learning algorithm for generating realistic synthetic electronic healthcare records (Prosate and Breast) |
Andreas Maier |
FAU Erlangen Nürnberg |
PLCO |
Jan 27, 2020 |
PLCO-570 |
Cell Free DNA Methylome for Lung Cancer Early Detection |
Rayjean Hung |
Sinai Health System |
PLCO |
Jan 23, 2020 |
2019-1024 |